Have a feature idea you'd love to see implemented?
Let us know!
GMED Globus Medical Inc
Price (delayed)
$82.63
Market cap
$11.25B
P/E Ratio
133.27
Dividend/share
N/A
EPS
$0.62
Enterprise value
$11.16B
Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing
Highlights
Globus Medical's revenue has surged by 102% YoY and by 11% QoQ
The gross profit has soared by 65% YoY and by 8% from the previous quarter
The EPS has surged by 148% since the previous quarter but it has dropped by 61% year-on-year
The company's net income has surged by 125% QoQ but it fell by 42% YoY
The P/E is 122% more than the 5-year quarterly average of 60.0
GMED's gross margin is down by 18% year-on-year and by 2.7% since the previous quarter
Key stats
What are the main financial stats of GMED
Market
Valuations
Earnings
Shares outstanding
136.17M
Market cap
$11.25B
Enterprise value
$11.16B
Price to earnings (P/E)
133.27
Price to book (P/B)
2.75
Price to sales (P/S)
4.52
EV/EBIT
86.78
EV/EBITDA
28.95
EV/Sales
4.5
Revenue
$2.48B
Gross profit
$1.44B
Net income
$91.51M
EBIT
$128.63M
EBITDA
$385.59M
Free cash flow
$293.77M
Per share
Balance sheet
Liquidity
EPS
$0.62
EPS diluted
$0.65
Free cash flow per share
$2.17
Book value per share
$30.05
Revenue per share
$18.28
TBVPS
$20.73
Total assets
$5.09B
Total liabilities
$1.02B
Debt
$534.56M
Equity
$4.07B
Working capital
$1.24B
Debt to equity
0.13
Current ratio
2.51
Quick ratio
1.57
Net debt/EBITDA
-0.23
Margins
Efficiency
Dividend
EBITDA margin
15.6%
Gross margin
58.1%
Net margin
3.7%
Operating margin
4.7%
Return on assets
1.8%
Return on equity
2.3%
Return on invested capital
6.2%
Return on capital employed
3%
Return on sales
5.2%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GMED stock price
How has the Globus Medical stock price performed over time
Intraday
0.84%
1 week
0.25%
1 month
-1.15%
1 year
59.3%
YTD
55.06%
QTD
15.5%
Financial performance
How have Globus Medical's revenue and profit performed over time
Revenue
$2.48B
Gross profit
$1.44B
Operating income
$115.84M
Net income
$91.51M
Gross margin
58.1%
Net margin
3.7%
The company's net income has surged by 125% QoQ but it fell by 42% YoY
The net margin has surged by 106% since the previous quarter but it has dropped by 71% year-on-year
Globus Medical's revenue has surged by 102% YoY and by 11% QoQ
The operating income has soared by 70% QoQ but it has decreased by 35% YoY
Growth
What is Globus Medical's growth rate over time
Valuation
What is Globus Medical stock price valuation
P/E
133.27
P/B
2.75
P/S
4.52
EV/EBIT
86.78
EV/EBITDA
28.95
EV/Sales
4.5
The EPS has surged by 148% since the previous quarter but it has dropped by 61% year-on-year
The P/E is 122% more than the 5-year quarterly average of 60.0
The stock's P/B is 31% more than its last 4 quarters average of 2.1 but 17% less than its 5-year quarterly average of 3.3
GMED's equity is down by 2.8% year-on-year but it is up by 2.3% since the previous quarter
Globus Medical's revenue has surged by 102% YoY and by 11% QoQ
GMED's P/S is 27% lower than its 5-year quarterly average of 6.2 but 16% higher than its last 4 quarters average of 3.9
Efficiency
How efficient is Globus Medical business performance
Globus Medical's return on equity has surged by 130% QoQ but it has shrunk by 64% YoY
The ROA has soared by 125% since the previous quarter but it has dropped by 67% year-on-year
GMED's ROIC has soared by 114% since the previous quarter but it is down by 35% year-on-year
The return on sales has surged by 79% since the previous quarter but it has dropped by 63% year-on-year
Dividends
What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GMED.
Financial health
How did Globus Medical financials performed over time
Globus Medical's current ratio has decreased by 44% YoY but it has increased by 3.7% QoQ
GMED's quick ratio is down by 30% year-on-year but it is up by 13% since the previous quarter
The debt is 87% smaller than the equity
The company's debt to equity rose by 8% YoY
GMED's equity is down by 2.8% year-on-year but it is up by 2.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.